FDA
approval
· 2016-10-24
FDA Approved: NYSTATIN AND TRIAMCINOLONE ACETONIDE — Original Application (Glenmark Pharmaceuticals Inc., USA)
Summary
FDA approved Glenmark's Nystatin and Triamcinolone Acetonide as an Original Application (ANDA) for a topical combination product indicated for inflammatory fung…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for NYSTATIN AND TRIAMCINOLONE ACETONIDE (NYSTATIN AND TRIAMCINOLONE ACETONIDE)